Holen Sie sich die Stockscreener-App
3.15
3.08%
-0.10
Schlusskurs vom Vortag:
$3.25
Offen:
$3.2
24-Stunden-Volumen:
77,255
Relative Volume:
0.09
Marktkapitalisierung:
$5.41M
Einnahmen:
$29.78M
Nettoeinkommen (Verlust:
$-39.94M
KGV:
-0.0509
EPS:
-61.9139
Netto-Cashflow:
$-16.12M
1W Leistung:
-1.25%
1M Leistung:
-45.03%
6M Leistung:
-95.76%
1J Leistung:
-99.07%
1-Tages-Spanne:
$3.07
$3.29
1-Wochen-Bereich:
$3.07
$3.4735
52-Wochen-Spanne:
$3.01
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Vergleichen Sie XXII mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
3.15 | 5.41M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
XXII stock plunges to 52-week low, touches $3.03 amid market rout - Investing.com Canada
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Sells Cannabis Operations - Tobacco Reporter
Investors Buy 22nd Shares ‘Above Market’ - Tobacco Reporter
22nd Century Launches Public Offering - Tobacco Reporter
22nd Century Submits CBD Drug Master File - Tobacco Reporter
22nd Century Eliminates $2.3 million of Debt - Tobacco Reporter
22nd Century Group (NASDAQ: XXII) and Smoker Friendly Forge New Agreement – Market - HPBL
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update - Defense World
22nd Century Group (NASDAQ:XXII) Regains Compliance with Nasdaq Listing Rule 5550(a)(2) - Defense World
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards - The Manila Times
22nd Century Group Regains Nasdaq Compliance, Secures Exchange Listing - StockTitan
22nd Century Group Announces Strategic Agreement with Smoker Friendly – Market - HPBL
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard - The Manila Times
22nd Century Group's VLN Cigarettes Already Meet FDA's Proposed Nicotine Reduction Standard - StockTitan
22nd Century Group Resets Conversion Price in Senior Secured Credit Facility - Defense World
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers - The Manila Times
22nd Century's VLN Cigarettes Take Spotlight as FDA's Nicotine Reduction Plan Advances - StockTitan
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish - MSN
22nd Century Group resets debt conversion price By Investing.com - Investing.com Canada
22nd Century Group resets debt conversion price - Investing.com
XXII22nd Century Group Inc. Latest Stock News & Market Updates - StockTitan
22nd Century ready to support FDA's reduced nicotine cigarette policy, stock up 30% - Seeking Alpha
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes - The Manila Times
22nd Century Group Ready to Lead FDA's Reduced Nicotine Cigarette Revolution with VLN Brand - StockTitan
22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results - Benzinga
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December - Benzinga
22nd Century & Smoker Friendly Expand Partnership - Tobacco Reporter
22nd Century Expands Market Reach with New Agreement - TipRanks
22nd Century Group, Inc. Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly International, LLC - Marketscreener.com
22nd Century Group signs expanded license and manufacturing agreement with Smoker Friendly - MSN
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly - The Manila Times
22nd Century Group Expands Smoker Friendly Partnership with Premium Brand Launch, 5-Year Deal - StockTitan
StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat
22nd Century Group announces reverse stock split By Investing.com - Investing.com Nigeria
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):